A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir

F. Lemaitre, L. Boland, C. Tron, A. L. Ruelland, V. Lelong-Boulouard, S. Baklouti, F. Goirand, N. Gambier, C. Boglione-Kerrien, B. Franck, S. Lalanne, A. Devresse, S. Briol,J. De Greef,V. Haufroid,M. Verdier

FUNDAMENTAL & CLINICAL PHARMACOLOGY（2023）

引用 0|浏览1